International Clinical Trial: A phase 1 trial in healthy adults and adults with increased inherited risk of developing blood clots

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ISRCTN45090913) titled 'A phase 1 trial in healthy adults and adults with increased inherited risk of developing blood clots' on Jan. 19.

Study Type: Interventional

Study Design: Interventional double blind randomized parallel group placebo controlled trial (Efficacy, Safety)

Primary Sponsor: City Therapeutics Inc.

Condition: Factor V Leiden or prothrombin G20210A mutation in healthy adults and adults Haematological Disorders

Intervention: The study will be conducted in two parts: Part A: Single Ascending Dose in Healthy Adults Part B: Single Ascending Dose in Adults with Factor V Leiden (FVL) or Prothrombin G20210A Mutation

Pa...